1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow Thalassemia: new trials by email Literature Review of Thalassemia trials Research Report on Thalassemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Denosumab Versus Zoledronic Acid in Thalassemia-Induced Osteoporosis Denosumab 60 MG/ML Prefilled Syringe, Zoledronic Acid 5Mg/Bag 100Ml Inj - Thalassemia Majors (Beta-Thalassemia Major), Osteoporosis | Phase 3 | Terminated | Hamad Medical Corporation | 17 | 2018-05-14 | 2019-12-12 |
Osteoporosis (1) · beta-Thalassemia (1)
Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Hematologic Diseases (1) · Hemic and Lymphatic Diseases (1) · Hemoglobinopathies (1) · Metabolic Diseases (1) · Musculoskeletal Diseases (1) · Nutritional and Metabolic Diseases (1)
Denosumab (1) · Zoledronic Acid (1)
Qatar (1)
Mohamed Yassin (1)